找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Immigranten im Wohlfahrtsstaat; am Beispiel der Rech Hubert Heinelt,Anne Lohmann Book 1992 Springer Fachmedien Wiesbaden 1992 Arbeit.Besch?

[復制鏈接]
樓主: incoherent
11#
發(fā)表于 2025-3-23 12:23:19 | 只看該作者
Hubert Heinelt,Anne Lohmann therapyof T-cell prolymphocytic leukemia and T-cell large granular lymphocyte leukemia, two rare CLL-related entities, are addressed...?.978-3-030-11392-6Series ISSN 2197-9766 Series E-ISSN 2197-9774
12#
發(fā)表于 2025-3-23 15:27:20 | 只看該作者
the CLL and the aggressive lymphoma clones. Rituximab-containing polychemotherapy is the back-bone treatment in DLBCL-type RS. Young patients who respond to induction therapy should be offered stem cell transplant to prolong survival. ABVD-related regimen is the preferred regimen for the HL variant
13#
發(fā)表于 2025-3-23 21:26:29 | 只看該作者
Hubert Heinelt,Anne Lohmannd potentially resulting in overexpression of BCL2, being an early feature of the disease in the majority of patients. However, genomic studies demonstrate a large array of additional molecular abnormalities with over 40 driver mutations potentially involved in the development of progressive disease.
14#
發(fā)表于 2025-3-24 01:12:44 | 只看該作者
Hubert Heinelt,Anne Lohmannt when selecting time and type of treatment in CLL patients. We gained further knowledge on the role of B-cell receptor (BcR) signaling and accumulated several hints supporting its key role in CLL development and progression. This led, for the first time in CLL history, to a targeted treatment appro
15#
發(fā)表于 2025-3-24 04:38:45 | 只看該作者
Hubert Heinelt,Anne Lohmannd potentially resulting in overexpression of BCL2, being an early feature of the disease in the majority of patients. However, genomic studies demonstrate a large array of additional molecular abnormalities with over 40 driver mutations potentially involved in the development of progressive disease.
16#
發(fā)表于 2025-3-24 09:01:55 | 只看該作者
17#
發(fā)表于 2025-3-24 10:52:05 | 只看該作者
18#
發(fā)表于 2025-3-24 18:25:46 | 只看該作者
19#
發(fā)表于 2025-3-24 21:13:37 | 只看該作者
are recognized, namely the diffuse large B-cell lymphoma (DLBCL) variant and the rare Hodgkin lymphoma (HL) variant. Histologic documentation is mandatory to diagnose RS. In the presence of clinical features suspicious of RS, diagnosis of transformation and choice of the site of biopsy may take adva
20#
發(fā)表于 2025-3-25 01:30:10 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-26 20:43
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
屏山县| 台江县| 神木县| 阜康市| 永昌县| 德化县| 永登县| 长葛市| 井冈山市| 桑日县| 昆山市| 郧西县| 塔河县| 辽中县| 临颍县| 敦煌市| 威信县| 峡江县| 肇东市| 建德市| 呼图壁县| 咸阳市| 武汉市| 隆尧县| 贵阳市| 克东县| 府谷县| 论坛| 湘潭县| 甘肃省| 和林格尔县| 红河县| 霍山县| 三原县| 巨鹿县| 定襄县| 从化市| 金平| 松溪县| 达孜县| 麦盖提县|